• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过潘天宁激酶 2 基因的断点测序扩展的泛酸激酶相关神经退行性变的基因突变谱。

Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene.

机构信息

Department of Laboratory Medicine, Kosin Gospel University Hospital, Busan, Korea.

Department of Laboratory Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.

出版信息

Orphanet J Rare Dis. 2022 Mar 4;17(1):111. doi: 10.1186/s13023-022-02251-7.

DOI:10.1186/s13023-022-02251-7
PMID:35246191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8896100/
Abstract

BACKGROUND

Neurodegeneration with brain iron accumulation describes a group of rare heterogeneous progressive neurodegenerative disorders characterized by excessive iron accumulation in the basal ganglia region. Pantothenate kinase-associated neurodegeneration (PKAN) is a major form of this disease.

RESULTS

A total of 7 unrelated patients were diagnosed with PKAN in a single tertiary center from August 2009 to February 2018. Ten variants in PANK2 including three novel sequence variants and one large exonic deletion were detected. Sequencing of the breakpoint was performed to predict the mechanism of large deletion and AluSx3 and AluSz6 were found with approximately 97.3% sequence homology.

CONCLUSION

The findings support the disease-causing role of PANK2 and indicate the possibility that exonic deletion of PANK2 found in PKAN is mediated through Alu-mediated homologous recombination.

摘要

背景

脑铁沉积相关神经退行性变描述了一组罕见的异质性进行性神经退行性疾病,其特征是基底节区域铁过度蓄积。泛酸激酶相关神经退行性变(PKAN)是该病的主要形式。

结果

2009 年 8 月至 2018 年 2 月,单一三级中心共诊断出 7 例 PKAN 患者。在 PANK2 中检测到包括三个新的序列变异和一个大外显子缺失在内的 10 种变异。对断点进行测序以预测大片段缺失的机制,发现 AluSx3 和 AluSz6 具有约 97.3%的序列同源性。

结论

这些发现支持 PANK2 的致病作用,并表明 PKAN 中发现的 PANK2 外显子缺失可能是通过 Alu 介导的同源重组介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbf/8896100/809e6f72af52/13023_2022_2251_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbf/8896100/82c0fcc7e428/13023_2022_2251_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbf/8896100/809e6f72af52/13023_2022_2251_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbf/8896100/82c0fcc7e428/13023_2022_2251_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbf/8896100/809e6f72af52/13023_2022_2251_Fig2_HTML.jpg

相似文献

1
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene.通过潘天宁激酶 2 基因的断点测序扩展的泛酸激酶相关神经退行性变的基因突变谱。
Orphanet J Rare Dis. 2022 Mar 4;17(1):111. doi: 10.1186/s13023-022-02251-7.
2
Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.硫辛酸补充剂可纠正潘特生激酶相关神经退行性变细胞模型中残留 PANK2 表达水平的病理改变。
Orphanet J Rare Dis. 2023 Apr 12;18(1):80. doi: 10.1186/s13023-023-02687-5.
3
Exploring Yeast as a Study Model of Pantothenate Kinase-Associated Neurodegeneration and for the Identification of Therapeutic Compounds.探讨酵母作为泛酸激酶相关神经退行性疾病的研究模型及治疗化合物的鉴定。
Int J Mol Sci. 2020 Dec 30;22(1):293. doi: 10.3390/ijms22010293.
4
Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.在一个塞浦路斯家族中发现导致非典型泛酸激酶相关神经变性(PKAN)的新型纯合PANK2突变。
J Neurol Sci. 2014 May 15;340(1-2):233-6. doi: 10.1016/j.jns.2014.03.001. Epub 2014 Mar 11.
5
Clinical and genetic features of PKAN patients in a tertiary centre in Turkey.土耳其一家三级医疗中心中PKAN患者的临床和遗传特征。
Clin Neurol Neurosurg. 2017 Mar;154:34-42. doi: 10.1016/j.clineuro.2017.01.011. Epub 2017 Jan 15.
6
Novel compound heterozygous PANK2 gene mutations in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.一名患有非典型泛酸激酶相关神经变性的中国患者中新型复合杂合PANK2基因突变
Int J Neurosci. 2018 Dec;128(12):1109-1113. doi: 10.1080/00207454.2018.1483364. Epub 2018 Aug 15.
7
Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation.泛酸激酶相关神经变性中,根据突变类型,泛酸盐可挽救铁蓄积。
Mol Neurobiol. 2019 May;56(5):3638-3656. doi: 10.1007/s12035-018-1333-0. Epub 2018 Sep 1.
8
Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.伴发于泛酸激酶相关神经退行性变成年型缓慢进行型的兄弟姐妹和 PANK2 中的一个新突变 Ile346Ser:临床特征和 (99m)Tc-ECD 脑灌注 SPECT 结果。
J Neurol Sci. 2010 Mar 15;290(1-2):172-6. doi: 10.1016/j.jns.2009.11.008. Epub 2009 Dec 14.
9
p.A170fs:a novel pathogenetic mutation, compound with p.R440P, causing pantothenate kinase Associated neurodegeneration in a Chinese family.p.A170fs:一种新的致病突变,与p.R440P复合,在中国一个家系中导致泛酸激酶相关神经变性。
Int J Neurosci. 2022 Jun;132(6):582-588. doi: 10.1080/00207454.2020.1828883. Epub 2020 Oct 14.
10
A Potential Citrate Shunt in Erythrocytes of PKAN Patients Caused by Mutations in Pantothenate Kinase 2.PKAN 患者红细胞中潜在的柠檬酸转移酶旁路是由于泛酸激酶 2 突变引起的。
Biomolecules. 2022 Feb 18;12(2):325. doi: 10.3390/biom12020325.

引用本文的文献

1
Case report: Asymmetric bilateral deep brain stimulation for the treatment of pantothenate kinase-associated neurodegeneration in a patient: a unique case of atypical PKAN with a novel heterozygous PANK2 mutation.病例报告:一名患者接受不对称双侧脑深部刺激治疗泛酸激酶相关神经变性:一例具有新型杂合PANK2突变的非典型PKAN独特病例。
Front Hum Neurosci. 2024 Oct 16;18:1448606. doi: 10.3389/fnhum.2024.1448606. eCollection 2024.

本文引用的文献

1
Natural history and genotype-phenotype correlation of pantothenate kinase-associated neurodegeneration.泛酸激酶相关神经退行性变的自然史和基因型-表型相关性。
CNS Neurosci Ther. 2020 Jul;26(7):754-761. doi: 10.1111/cns.13294. Epub 2020 Feb 11.
2
Incidence of PKAN determined by bioinformatic and population-based analysis of ~140,000 humans.通过对约 14 万人的生物信息学和基于人群的分析确定 PKAN 的发病率。
Mol Genet Metab. 2019 Dec;128(4):463-469. doi: 10.1016/j.ymgme.2019.09.002. Epub 2019 Sep 12.
3
A therapeutic approach to pantothenate kinase associated neurodegeneration.
泛酸激酶相关神经退行性疾病的治疗方法。
Nat Commun. 2018 Oct 23;9(1):4399. doi: 10.1038/s41467-018-06703-2.
4
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.神经退行性疾病患者PANK2和PLA2G6基因的新突变:两例病例报告。
BMC Med Genet. 2017 Aug 18;18(1):87. doi: 10.1186/s12881-017-0439-y.
5
A variation in PANK2 gene is causing Pantothenate kinase-associated Neurodegeneration in a family from Jammu and Kashmir - India.一个 PANK2 基因突变导致了来自印度查谟和克什米尔的一个家族的泛酸激酶相关神经退行性变。
Sci Rep. 2017 Jul 5;7(1):4834. doi: 10.1038/s41598-017-05388-9.
6
Retrotransposons as regulators of gene expression.逆转录转座子作为基因表达的调控因子。
Science. 2016 Feb 12;351(6274):aac7247. doi: 10.1126/science.aac7247. Epub 2016 Feb 11.
7
Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans.韩国人中非典型泛酸激酶相关神经退行性变的临床异质性。
J Mov Disord. 2016 Jan;9(1):20-7. doi: 10.14802/jmd.15058. Epub 2016 Jan 25.
8
Neurodegeneration with Brain Iron Accumulation.脑铁蓄积性神经退行性变。
Curr Neurol Neurosci Rep. 2016 Jan;16(1):9. doi: 10.1007/s11910-015-0608-3.
9
The contribution of alu elements to mutagenic DNA double-strand break repair.Alu 元件对诱变 DNA 双链断裂修复的贡献。
PLoS Genet. 2015 Mar 11;11(3):e1005016. doi: 10.1371/journal.pgen.1005016. eCollection 2015 Mar.
10
Physiological roles of the pantothenate kinases.泛酸激酶的生理作用。
Biochem Soc Trans. 2014 Aug;42(4):1033-6. doi: 10.1042/BST20140096.